A Possible Blood Test for Early-Stage Alzheimer's Disease

A multi-institutional study published in Science Advances details a potential blood test for identifying early-stage Alzheimer's, reports Medical Xpress . The researchers determined that adding the EPPS molecule to a solution containing amyloid-beta (Aß) peptide concentrations would break them down, suggesting that testing the broken samples from persons diagnosed with early-stage Alzheimer's against control groups would uncover differences. According to the team, this test reliably differentiates between people diagnosed with the disease and the control group. They also demonstrated that the method could be used as a way to monitor disease progression. Looking ahead, they are planning to make the technique available to doctors in clinical practice.